Anticoagulant Use in COVID-19 Patients: A Longitudinal Study From Zanjan, Iran

DOI record: { "DOI": "10.7759/cureus.66798", "ISSN": [ "2168-8184" ], "URL": "http://dx.doi.org/10.7759/cureus.66798", "author": [ { "affiliation": [], "family": "Azimi Pirsaraei", "given": "Vanoushe", "sequence": "first" }, { "affiliation": [], "family": "Jozpanahi", "given": "Manizhe", "sequence": "additional" }, { "affiliation": [], "family": "Kamali", "given": "Koorosh", "sequence": "additional" }, { "affiliation": [], "family": "Hamzeloo", "given": "Leila", "sequence": "additional" }, { "affiliation": [], "family": "Saeid", "given": "Seyedeh Pegah", "sequence": "additional" } ], "container-title": "Cureus", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2024, 8, 13 ] ], "date-time": "2024-08-13T21:49:17Z", "timestamp": 1723585757000 }, "deposited": { "date-parts": [ [ 2024, 8, 13 ] ], "date-time": "2024-08-13T21:49:24Z", "timestamp": 1723585764000 }, "indexed": { "date-parts": [ [ 2024, 8, 14 ] ], "date-time": "2024-08-14T00:29:10Z", "timestamp": 1723595350682 }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2024, 8, 13 ] ] }, "language": "en", "link": [ { "URL": "https://www.cureus.com/articles/263779-anticoagulant-use-in-covid-19-patients-a-longitudinal-study-from-zanjan-iran", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "prefix": "10.7759", "published": { "date-parts": [ [ 2024, 8, 13 ] ] }, "published-print": { "date-parts": [ [ 2024, 8, 13 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "DOI": "10.1111/bjh.16727", "article-title": "Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action", "author": "Kollias A", "doi-asserted-by": "publisher", "journal-title": "Br J Haematol", "key": "ref1", "unstructured": "Kollias A, Kyriakoulis KG, Dimakakos E, Poulakou G, Stergiou GS, Syrigos K. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol. 2020, 189:846-7. 10.1111/bjh.16727", "volume": "189", "year": "2020" }, { "DOI": "10.1007/s11684-020-0767-8", "article-title": "Coronavirus disease 2019 (COVID-19): a clinical update", "author": "Zhou M", "doi-asserted-by": "publisher", "journal-title": "Front Med", "key": "ref2", "unstructured": "Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID-19): a clinical update. Front Med. 2020, 14:126-35. 10.1007/s11684-020-0767-8", "volume": "14", "year": "2020" }, { "article-title": "Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period", "author": "Ozma MA", "journal-title": "Infez Med", "key": "ref3", "unstructured": "Ozma MA, Maroufi P, Khodadadi E, et al.. Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period. Infez Med. 2020, 28:153-65.", "volume": "28", "year": "2020" }, { "DOI": "10.1016/j.jacc.2020.04.031", "article-title": "COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review", "author": "Bikdeli B", "doi-asserted-by": "publisher", "journal-title": "J Am Coll Cardiol", "key": "ref4", "unstructured": "Bikdeli B, Madhavan MV, Jimenez D, et al.. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 75:2950-73. 10.1016/j.jacc.2020.04.031", "volume": "75", "year": "2020" }, { "DOI": "10.1007/s11239-020-02125-4", "article-title": "Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines", "author": "Porfidia A", "doi-asserted-by": "publisher", "journal-title": "J Thromb Thrombolysis", "key": "ref5", "unstructured": "Porfidia A, Pola R. Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines. J Thromb Thrombolysis. 2020, 50:68-71. 10.1007/s11239-020-02125-4", "volume": "50", "year": "2020" }, { "DOI": "10.1183/13993003.00607-2020", "article-title": "Pathogenesis of COVID-19 from a cell biology perspective", "author": "Mason RJ", "doi-asserted-by": "publisher", "journal-title": "Eur Respir J", "key": "ref6", "unstructured": "Mason RJ. Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J. 2020, 55:2000607. 10.1183/13993003.00607-2020", "volume": "55", "year": "2020" }, { "DOI": "10.1016/j.mehy.2020.109975", "article-title": "Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?", "author": "Mohamed-Hussein AA", "doi-asserted-by": "publisher", "journal-title": "Med Hypotheses", "key": "ref7", "unstructured": "Mohamed-Hussein AA, Aly KM, Ibrahim MA. Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?. Med Hypotheses. 2020, 144:109975. 10.1016/j.mehy.2020.109975", "volume": "144", "year": "2020" }, { "DOI": "10.1007/s11239-020-02138-z", "article-title": "Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum", "author": "Barnes GD", "doi-asserted-by": "publisher", "journal-title": "J Thromb Thrombolysis", "key": "ref8", "unstructured": "Barnes GD, Burnett A, Allen A, et al.. Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis. 2020, 50:72-81. 10.1007/s11239-020-02138-z", "volume": "50", "year": "2020" }, { "DOI": "10.1007/s00134-020-06062-x", "article-title": "High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study", "author": "Helms J", "doi-asserted-by": "publisher", "journal-title": "Intensive Care Med", "key": "ref9", "unstructured": "Helms J, Tacquard C, Severac F, et al.. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020, 46:1089-98. 10.1007/s00134-020-06062-x", "volume": "46", "year": "2020" }, { "DOI": "10.1016/j.thromres.2020.04.013", "article-title": "Incidence of thrombotic complications in critically ill ICU patients with COVID-19", "author": "Klok FA", "doi-asserted-by": "publisher", "journal-title": "Thromb Res", "key": "ref10", "unstructured": "Klok FA, Kruip MJ, van der Meer NJ, et al.. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020, 191:145-7. 10.1016/j.thromres.2020.04.013", "volume": "191", "year": "2020" }, { "DOI": "10.3389/fpubh.2020.551889", "article-title": "Iran's approach to COVID-19: evolving treatment protocols and ongoing clinical trials", "author": "Rahmanzade R", "doi-asserted-by": "publisher", "journal-title": "Front Public Health", "key": "ref11", "unstructured": "Rahmanzade R, Rahmanzadeh R, Hashemian SM, Tabarsi P. Iran's approach to COVID-19: evolving treatment protocols and ongoing clinical trials. Front Public Health. 2020, 8:551889. 10.3389/fpubh.2020.551889", "volume": "8", "year": "2020" }, { "DOI": "10.1155/2021/6697677", "article-title": "Correlation between chest CT severity scores and the clinical parameters of adult patients with COVID-19 pneumonia", "author": "Saeed GA", "doi-asserted-by": "publisher", "journal-title": "Radiol Res Pract", "key": "ref12", "unstructured": "Saeed GA, Gaba W, Shah A, et al.. Correlation between chest CT severity scores and the clinical parameters of adult patients with COVID-19 pneumonia. Radiol Res Pract. 2021, 2021:6697677. 10.1155/2021/6697677", "volume": "2021", "year": "2021" }, { "DOI": "10.1016/j.cca.2020.05.044", "article-title": "COVID-19: transmission, prevention, and potential therapeutic opportunities", "author": "Lotfi M", "doi-asserted-by": "publisher", "journal-title": "Clin Chim Acta", "key": "ref13", "unstructured": "Lotfi M, Hamblin MR, Rezaei N. COVID-19: transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta. 2020, 508:254-66. 10.1016/j.cca.2020.05.044", "volume": "508", "year": "2020" }, { "DOI": "10.1016/j.jamda.2020.05.045", "article-title": "The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects", "author": "Bonanad C", "doi-asserted-by": "publisher", "journal-title": "J Am Med Dir Assoc", "key": "ref14", "unstructured": "Bonanad C, García-Blas S, Tarazona-Santabalbina F, et al.. The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects. J Am Med Dir Assoc. 2020, 21:915-8. 10.1016/j.jamda.2020.05.045", "volume": "21", "year": "2020" }, { "DOI": "10.1186/s13293-020-00330-7", "article-title": "Sex differences in severity and mortality from COVID-19: are males more vulnerable?", "author": "Pradhan A", "doi-asserted-by": "publisher", "journal-title": "Biol Sex Differ", "key": "ref15", "unstructured": "Pradhan A, Olsson PE. Sex differences in severity and mortality from COVID-19: are males more vulnerable?. Biol Sex Differ. 2020, 11:53. 10.1186/s13293-020-00330-7", "volume": "11", "year": "2020" }, { "DOI": "10.34172/aim.2020.102", "article-title": "Clinical characteristics and outcomes of 905 COVID-19 patients admitted to Imam Khomeini Hospital Complex in the capital city of Tehran, Iran", "author": "Allameh SF", "doi-asserted-by": "publisher", "journal-title": "Arch Iran Med", "key": "ref16", "unstructured": "Allameh SF, Nemati S, Ghalehtaki R, et al.. Clinical characteristics and outcomes of 905 COVID-19 patients admitted to Imam Khomeini Hospital Complex in the capital city of Tehran, Iran. Arch Iran Med. 2020, 23:766-75. 10.34172/aim.2020.102", "volume": "23", "year": "2020" }, { "DOI": "10.1016/j.eclinm.2021.100789", "article-title": "COPD and the risk of poor outcomes in COVID-19: a systematic review and meta-analysis", "author": "Gerayeli FV", "doi-asserted-by": "publisher", "journal-title": "EClinicalMedicine", "key": "ref17", "unstructured": "Gerayeli FV, Milne S, Cheung C, et al.. COPD and the risk of poor outcomes in COVID-19: a systematic review and meta-analysis. EClinicalMedicine. 2021, 33:100789. 10.1016/j.eclinm.2021.100789", "volume": "33", "year": "2021" }, { "DOI": "10.23750/abm.v92i3.10630", "article-title": "Predictors of clinical outcomes in adult COVID-19 patients admitted to a tertiary care hospital in India: an analytical cross-sectional study", "author": "Chauhan NK", "doi-asserted-by": "publisher", "journal-title": "Acta Biomed", "key": "ref18", "unstructured": "Chauhan NK, Shadrach BJ, Garg MK, et al.. Predictors of clinical outcomes in adult COVID-19 patients admitted to a tertiary care hospital in India: an analytical cross-sectional study. Acta Biomed. 2021, 92:e2021024. 10.23750/abm.v92i3.10630", "volume": "92", "year": "2021" }, { "DOI": "10.1093/jac/dkaa403", "article-title": "Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis", "author": "Kashour Z", "doi-asserted-by": "publisher", "journal-title": "J Antimicrob Chemother", "key": "ref19", "unstructured": "Kashour Z, Riaz M, Garbati MA, et al.. Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis. J Antimicrob Chemother. 2021, 76:30-42. 10.1093/jac/dkaa403", "volume": "76", "year": "2021" }, { "DOI": "10.1080/14787210.2021.1848545", "article-title": "Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: a systematic review", "author": "Joseph BA", "doi-asserted-by": "publisher", "journal-title": "Expert Rev Anti Infect Ther", "key": "ref20", "unstructured": "Joseph BA, Dibas M, Evanson KW, et al.. Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: a systematic review. Expert Rev Anti Infect Ther. 2021, 19:679-87. 10.1080/14787210.2021.1848545", "volume": "19", "year": "2021" }, { "DOI": "10.1101/2020.07.20.20157891", "article-title": "Intravenous immunoglobulin (IVIG) significantly reduces respiratory morbidity in COVID-19 pneumonia: a prospective randomized trial", "author": "Sakoulas G", "doi-asserted-by": "publisher", "journal-title": "medRxiv", "key": "ref21", "unstructured": "Sakoulas G, Geriak M, Kullar R, et al.. Intravenous immunoglobulin (IVIG) significantly reduces respiratory morbidity in COVID-19 pneumonia: a prospective randomized trial. medRxiv. 2020, 10.1101/2020.07.20.20157891", "year": "2020" }, { "DOI": "10.1016/j.intimp.2020.107205", "article-title": "Evaluating the effects of intravenous immunoglobulin (IVIg) on the management of severe COVID-19 cases: a randomized controlled trial", "author": "Tabarsi P", "doi-asserted-by": "publisher", "journal-title": "Int Immunopharmacol", "key": "ref22", "unstructured": "Tabarsi P, Barati S, Jamaati H, et al.. Evaluating the effects of intravenous immunoglobulin (IVIg) on the management of severe COVID-19 cases: a randomized controlled trial. Int Immunopharmacol. 2021, 90:107205. 10.1016/j.intimp.2020.107205", "volume": "90", "year": "2021" }, { "DOI": "10.3390/medicina57090931", "article-title": "Aspirin is related to worse clinical outcomes of COVID-19", "author": "Kim I", "doi-asserted-by": "publisher", "journal-title": "Medicina (Kaunas)", "key": "ref23", "unstructured": "Kim I, Yoon S, Kim M, Lee H, Park S, Kim W, Lee S. Aspirin is related to worse clinical outcomes of COVID-19. Medicina (Kaunas). 2021, 57:931. 10.3390/medicina57090931", "volume": "57", "year": "2021" }, { "DOI": "10.1161/JAHA.121.024530", "article-title": "Aspirin therapy on prophylactic anticoagulation for patients hospitalized with COVID-19: a propensity score-matched cohort analysis of the HOPE-COVID-19 Registry", "author": "Santoro F", "doi-asserted-by": "publisher", "journal-title": "J Am Heart Assoc", "key": "ref24", "unstructured": "Santoro F, Núñez-Gil IJ, Vitale E, et al.. Aspirin therapy on prophylactic anticoagulation for patients hospitalized with COVID-19: a propensity score-matched cohort analysis of the HOPE-COVID-19 Registry. J Am Heart Assoc. 2022, 11:e024530. 10.1161/JAHA.121.024530", "volume": "11", "year": "2022" }, { "DOI": "10.1136/openhrt-2021-001785", "article-title": "Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study", "author": "Matli K", "doi-asserted-by": "publisher", "journal-title": "Open Heart", "key": "ref25", "unstructured": "Matli K, Chamoun N, Fares A, et al.. Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study. Open Heart. 2021, 8:e001785. 10.1136/openhrt-2021-001785", "volume": "8", "year": "2021" }, { "DOI": "10.1007/s15010-022-01809-8", "article-title": "Efficacy of different anticoagulant doses for patients with COVID-19: a systematic review and network meta-analysis", "author": "Yasuda H", "doi-asserted-by": "publisher", "journal-title": "Infection", "key": "ref26", "unstructured": "Yasuda H, Mayumi T, Okano H. Efficacy of different anticoagulant doses for patients with COVID-19: a systematic review and network meta-analysis. Infection. 2022, 50:1453-63. 10.1007/s15010-022-01809-8", "volume": "50", "year": "2022" }, { "DOI": "10.1016/j.cmi.2020.07.030", "article-title": "CT lung lesions as predictors of early death or ICU admission in COVID-19 patients", "author": "Ruch Y", "doi-asserted-by": "publisher", "journal-title": "Clin Microbiol Infect", "key": "ref27", "unstructured": "Ruch Y, Kaeuffer C, Ohana M, et al.. CT lung lesions as predictors of early death or ICU admission in COVID-19 patients. Clin Microbiol Infect. 2020, 26:1417.e5-8. 10.1016/j.cmi.2020.07.030", "volume": "26", "year": "2020" }, { "DOI": "10.1371/journal.pone.0244171", "article-title": "Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru", "author": "Mejía F", "doi-asserted-by": "publisher", "journal-title": "PLoS One", "key": "ref28", "unstructured": "Mejía F, Medina C, Cornejo E, et al.. Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru. PLoS One. 2020, 15:e0244171. 10.1371/journal.pone.0244171", "volume": "15", "year": "2020" } ], "reference-count": 28, "references-count": 28, "relation": {}, "resource": { "primary": { "URL": "https://www.cureus.com/articles/263779-anticoagulant-use-in-covid-19-patients-a-longitudinal-study-from-zanjan-iran" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Anticoagulant Use in COVID-19 Patients: A Longitudinal Study From Zanjan, Iran", "type": "journal-article" }